Foundation Medicine, Inc.
Healthcare · Services-Medical Laboratories · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|---|---|
| Revenue | $26.3M | $30.4M | $93.2M | $61.1M | $29.0M | $10.6M |
| Operating income | −$160.9M | −$113.8M | −$89.8M | −$53.3M | −$41.8M | −$21.9M |
| Net income | −$161.5M | −$113.2M | −$89.6M | −$52.2M | −$42.9M | −$22.4M |
| Total assets | $169.0M | $214.0M | $298.0M | $111.9M | $157.3M | $66.0M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $31.7M | $164.8M | $257.7M | $86.2M | $131.7M | −$43.4M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 35.4M | 34.5M | 29.1M | 27.7M | 27.6M | 2.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- −611.3%
- Net margin
- −613.3%
- Return on equity
- −509.9%
- Return on assets
- −95.5%
- Return on capital (ROCE)
- −156.9%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $0.89
- Revenue growth (YoY)
- −13.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Accruals / assets
- −23.9%clean
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 4 warning● 1 good- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsJul 31, 2018
- Shareholder voteJun 21, 2018
- Entered a material agreement · Regulation FD disclosureJun 19, 2018
- Entered a material agreementJun 7, 2018
- Results of operationsMay 2, 2018
- Other material eventMar 19, 2018
- Results of operationsMar 7, 2018
- Entered a material agreementMar 5, 2018
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- CT ORDERSep 27, 2018
- 10-Q/ASep 18, 2018
- 15-12BAug 10, 2018
- 10-QAug 9, 2018
- S-8 POSFORM S-8 POSAug 3, 2018
- S-8 POSFORM S-8 POSAug 3, 2018
- S-8 POSFORM S-8 POSAug 3, 2018
- S-8 POSFORM S-8 POSAug 3, 2018
- S-8 POSFORM S-8 POSAug 3, 2018
- 4Aug 2, 2018
- 4FORM 4 SUBMISSIONAug 2, 2018
- 4FORM 4 SUBMISSIONAug 2, 2018
- 4FORM 4 SUBMISSIONAug 2, 2018
- 4FORM 4 SUBMISSIONAug 2, 2018
- 4FORM 4 SUBMISSIONAug 2, 2018